Production (Stage)
Evolent Health, Inc.
EVH
$7.21
-$0.15-2.04%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -25.19% | 4.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -25.19% | 4.05% | |||
| Cost of Revenue | -33.22% | 5.57% | |||
| Gross Profit | 35.34% | -6.17% | |||
| SG&A Expenses | 63.21% | -29.91% | |||
| Depreciation & Amortization | -17.88% | -1.36% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -25.53% | 1.52% | |||
| Operating Income | 391.28% | 96.36% | |||
| Income Before Tax | -163.96% | -0.70% | |||
| Income Tax Expenses | 231.13% | -81.10% | |||
| Earnings from Continuing Operations | -183.39% | 1.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -183.39% | 1.45% | |||
| EBIT | 391.28% | 96.36% | |||
| EBITDA | -70.57% | 801.84% | |||
| EPS Basic | -135.44% | 2.13% | |||
| Normalized Basic EPS | -909.97% | 74.96% | |||
| EPS Diluted | -135.44% | 2.13% | |||
| Normalized Diluted EPS | -909.97% | 74.96% | |||
| Average Basic Shares Outstanding | 0.25% | 0.15% | |||
| Average Diluted Shares Outstanding | 0.25% | 0.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.66% | 0.05% | |||